Patents by Inventor Makoto Yoshihama
Makoto Yoshihama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6844183Abstract: Antibiotics RK-1061s having a novel chemical structure and a method of production thereof. They have a structural formula represented by general formula(I) wherein A represents R1 or R1CH(OR2)CH2. R2 represents 3-methylglutaric acid residue and R3 represents a sulfate group or a hydrogen atom. The process comprises culturing a ray fungus belonging to the genus Streptomyces and isolating RK-1061s from the culture. Streptomyces sp. SN-1061Ms (FERM BP-5800) is capable of stably producing RK-1061 at a high productivity.Type: GrantFiled: August 5, 2002Date of Patent: January 18, 2005Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Ken-ichi Kimura, Yoshikazu Ikeda, Shinobu Kagami, Hidetoshi Takahashi, Kousaku Takahashi, Makoto Yoshihama, Makoto Ubutaka, Kiyoshi Isono
-
Patent number: 6559157Abstract: Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.Type: GrantFiled: May 25, 2001Date of Patent: May 6, 2003Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Rolf Wolfgang Hartmann, Bertil Wachall, Makoto Yoshihama, Masamichi Nakakoshi, Shin Nomoto, Yoshikazu Ikeda
-
Publication number: 20030050471Abstract: Antibiotics RK-1061s having a novel chemical structure and a method of production thereof.Type: ApplicationFiled: August 5, 2002Publication date: March 13, 2003Applicant: Daiichi Pharmaceutical Co., Ltd.Inventors: Ken-Ichi Kimura, Yoshikazu Ikeda, Shinobu Kagami, Hidetoshi Takahashi, Kousaku Takahashi, Makoto Yoshihama, Makoto Ubukata, Kiyoshi Isono
-
Patent number: 6455694Abstract: Antibiotics RK-1061s having a novel chemical structure and a method of production thereof. They have a structural formula represented by general formula(I) wherein A represents R1 or R1CH(OR2)CH2. R2 represents 3-methylglutaric acid residue and R3 represents a sulfate group or a hydrogen atom. The process comprises culturing a ray fungus belonging to the genus Streptomyces and isolating RK-1061s from the culture. Streptomyces sp. SN-1061Ms (FERM BP-5800) is capable of stably producing RK-1061 at a high productivity.Type: GrantFiled: January 12, 1999Date of Patent: September 24, 2002Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Ken-ichi Kimura, Yoshikazu Ikeda, Shinobu Kagami, Hidetoshi Takahashi, Kousaku Takahashi, Makoto Yoshihama, Makoto Ubukata, Kiyoshi Isono
-
Publication number: 20020032211Abstract: Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.Type: ApplicationFiled: May 25, 2001Publication date: March 14, 2002Inventors: Rolf Wolfgang Hartmann, Bertil Wachall, Makoto Yoshihama, Masamichi Nakakoshi, Shin Nomoto, Yoshikazu Ikeda
-
Patent number: 6143779Abstract: The present invention provides new benzofuranone derivatives and a method for producing the derivatives useful for a therapeutic agent for preventing and/or treating hormone dependent diseases.The present invention is a new benzofuranone derivative represented by a particular general formula (I). ##STR1## In the production, a particular benzofuranone compound and a particular benzaldehyde are reacted.Type: GrantFiled: December 7, 1998Date of Patent: November 7, 2000Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Makoto Yoshihama, Masamichi Nakakoshi, Junji Nakamura, Shoji Nakayama
-
Patent number: 6080781Abstract: The present invention provides new tetralone or benzopyranone derivatives and a method for producing the derivatives useful for a therapeutic agent for preventing and/or treating hormone dependent diseases. The present invention is a new tetralone or benzopyranone derivative represented by a particular general formula (I). ##STR1## wherein R.sub.1 and R.sub.2 represent hydrogen, a hydroxy group, an alkyloxy group or an aralkyloxy group, respectively, R.sub.3 -R.sub.7 represent hydrogen, a hydroxy group or a straight or branched alkyl, alkyloxy or aralkyloxy group having 1-6 carbon atoms, a halogen, an amino group or an alkylene dioxy group joined at R.sub.3 and R.sub.4, R.sub.4 and R.sub.5, R.sub.5 and R.sub.6, or R.sub.6 and R.sub.7, respectively, and A represents a methylene or oxygen.In the production, a particular tetralone or benzopyranone compound and a particular benzaldehyde compound are reacted.Type: GrantFiled: January 19, 1999Date of Patent: June 27, 2000Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Makoto Yoshihama, Masamichi Nakakoshi, Junji Nakamura, Shoji Nakayama
-
Patent number: 5914227Abstract: The invention relates to an examination method of hormone-dependent tissue, more particularly to a method for examining hormone-dependent tumors by culturing a tumor tissue in (a) a control culture medium, (b) a culture medium containing a hormone synthetase substrate, and (c) a culture medium containing a hormone synthetase substrate and a hormone synthetase inhibitor, and determining the relative growth ratios of tumor cells of (b) to (a), and (c) to (a) for diagnosing a tumor as being hormone dependent.This invention provides a method for the simultaneous and easy determination of hormone dependent tumors and the presence of hormone synthetic enzymes. Further, this invention provides a new classification system for tumors and means for indicating medical treatment for a cancer patient.Type: GrantFiled: July 14, 1997Date of Patent: June 22, 1999Inventors: Junji Nakamura, Makoto Yoshihama
-
Patent number: 5449750Abstract: Prolyl endopeptidase inhibiting compounds SNA-115 and SNA-115T are provided having molecular formulas of C.sub.113 H.sub.142 N.sub.26 O.sub.27 and C.sub.113 H.sub.144 N.sub.26 O.sub.28 respectively. SNA-115T has the following structural formula:Arg Tyr Asp Trp Trp Pro Tyr Gly Asp Leu Phe Gly Gly His Thr Phe Ile Ser ProProcesses are also provided for the production of SNA-11 by culturing the SNA productive microorganism and production of SNA-115T by degradation of SNA-115 with trypsin. Both SNA-115 and SNA-115T exhibit prolyl endopeptidase inhibitory properties.Type: GrantFiled: February 17, 1993Date of Patent: September 12, 1995Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Kenichi Kimura, Fumiko Kanou, Hidetoshi Takahashi, Kazuhiko Kurosawa, Makoto Yoshihama
-
Patent number: 5428175Abstract: A physiologically active compound HS-1 having the following chemical structure is disclosed. This compound is prepared by culturing Chromobacterium violaceum, adding tryptophan and diethyldithiocarbamate (diethyldithiocarbamic acid) to the culture broth for reacting with the cells for producing HS-1 in the cells, and collecting the compound from the culture broth. This novel compound possesses antitumor and antimicrobial activity, and is effective as an antitumor agent or an antimicrobial agent.Type: GrantFiled: February 18, 1994Date of Patent: June 27, 1995Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Tsutomu Hoshino, Takeo Uchiyama, Kenichi Kimura, Hidetoshi Takahashi, Makoto Yoshihama
-
Patent number: 5166200Abstract: A remedy for endometriosis comprising, as an active ingredient, 14.alpha.-hydroxy-4-androstene-3,6,17-trione or an ester derivative thereof, can effectively treat endometriosis by the strong aromatase-inhibitory activity without giving serious side effects.Type: GrantFiled: April 11, 1991Date of Patent: November 24, 1992Assignee: Snow Brand Milk Products Company, LimitedInventors: Nobuaki Fujise, Yasushi Yamashita, Hiroaki Takaoka, Nobuyoshi Honda, Makoto Yoshihama
-
Patent number: 5164302Abstract: Novel 7.beta.-hydroxy-4-pregnene-3,20-dione derivatives are disclosed.The group of these compounds has possibility of being utilized as an intermediate for the synthesis of progesterone derivatives having ovulation-inhibiting activity. These compounds themselves have also cell differentiation activity for M1 cells.Type: GrantFiled: November 15, 1989Date of Patent: November 17, 1992Assignee: Snow Brand Milk Products Company, LimitedInventors: Makoto Yoshihama, Koji Tamura, Nobuo Miyata, Masamichi Nakakoshi
-
Patent number: 5098535Abstract: A process for the preparation in high yield of 14.alpha.-hydroxy-4-androstene-3,6,17-trione which has an aromatase inhibition activity and is useful as an antitumor agent, in which the 6.beta.-hydroxyl group of 6.beta., 14.alpha.-dihydroxy-4-androstene-3,17-dione is selectively oxidized with the aid of visible light energy.Type: GrantFiled: February 6, 1990Date of Patent: March 24, 1992Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Masamichi Nakakoshi, Kohji Tamura, Makoto Yoshihama, Nobuo Miyata
-
Patent number: 5079377Abstract: Novel androst-4-ene-3,17-dione derivatives are disclosed. The group of these compounds has biological activities, in particular, the inhibiting activity on human placenta-derived estrogen-synthesizing enzyme. Therefore these compounds are expected to be utilized in the field of medical care, particularly as anticancer drugs.Type: GrantFiled: July 23, 1990Date of Patent: January 7, 1992Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Makoto Yoshihama, Koji Tamura, Nobuo Miyata, Shoji Nakayama, Masamichi Nakakoshi
-
Patent number: 5028722Abstract: Novel 7.beta.-hydroxy-4-pregnene-3,20-dione derivatives are disclosed.The group of these compounds has possibility of being utilized as an intermediate for the synthesis of progesterone derivatives having ovulation-inhibiting activity. These compounds themselves have also cell differentiation activity for M1 cells.Type: GrantFiled: September 26, 1988Date of Patent: July 2, 1991Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Makoto Yoshihama, Koji Tamura, Nobuo Miyata, Masamichi Nakakoshi
-
Patent number: 4975368Abstract: Novel androst-4-ene-3,17-dione derivatives are disclosed. The group of these compounds has biological activities, in particular, the inhibiting activity on human placenta-derived estrogen-synthesizing enzyme. Therefore these compounds are expected to be utilized in the field of medical care, particularly as anticancer drugs.Type: GrantFiled: September 26, 1988Date of Patent: December 4, 1990Assignee: Snow Brand Milk Products Co., Ltd.Inventors: Makoto Yoshihama, Koji Tamura, Nobuo Miyata, Shoji Nakayama, Masamichi Nakakoshi
-
Patent number: 4649119Abstract: The invention is a method for obtaining a chimeric plasmid which can serve as a vector for inserting one or more foreign or native genes into Corynebacterium and a second species of bacteria. The plasmid is the ligation product of plasmid DNA from Corynebacterium as well as plasmid DNA from a non-Corynebacterium species of bacteria. Also disclosed is a method for forming protoplasts from Corynebacterium organisms and transforming the protoplasts with vectors, e.g., the chimeric plasmids of the invention.Type: GrantFiled: April 28, 1983Date of Patent: March 10, 1987Assignee: Massachusetts Institute of TechnologyInventors: Anthony J. Sinskey, Graham C. Walker, Kanji Higashio, Eswara A. Rao, William G. Shanabruch, Makoto Yoshihama